Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.
复制标题
DOI：
10.1016/j.ypmed.2021.106595
复制
发表时间：
2021-10
影响因子：
5.1
通讯作者：
National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium
中科院分区：
文献类型：
--
作者：
Croswell JM;Corley DA;Lafata JE;Haas JS;Inadomi JM;Kamineni A;Ritzwoller DP;Vachani A;Zheng Y;National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium
事实证明，COVID-19对癌症筛查的提供具有巨大的破坏性，癌症筛查不仅仅是一种初步测试，而是一个包括风险检测、诊断随访和治疗的整个过程。在这一进程的各个阶段，服务的成功提供受到了这一流行病的不利影响。在流行病及其缓解阶段，缺乏高质量的经验证据来支持实施癌症筛查的具体策略，但一些务实的考虑可以帮助指导优先工作。针对那些从未接受过筛查的符合指南的人，或者那些明显过时的筛查者，有可能在现在和将来最大限度地获益。由于大流行而导致的护理中断可能代表着一个前所未有的机会，可以重新评估早期检测计划，以明确，周到和公正地优先考虑历史上经历癌症差异的人群。通过将筛查服务重点放在受益最大的人群上，并通过对大流行后的时期进行仔细和深思熟虑的规划，我们可以对所有人的癌症结果产生积极影响。
COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmatic considerations can help guide prioritization efforts. Targeting guideline-eligible people who have never been screened, or those who are significantly out of date with screening, has the potential to maximize benefits now and into the future. Disruptions to care due to the pandemic could represent an unparalleled opportunity to reassess early detection programs towards an explicit, thoughtful, and just prioritization of populations historically experiencing cancer disparities. By focusing screening services on populations that have the most to gain, and by careful and deliberate planning for the period following the pandemic, we can positively affect cancer outcomes for all.
登录
查看更多内容
影响因子：
2.8
作者：
Cancino RS;Su Z;Mesa R;Tomlinson GE;Wang J
通讯作者：
Wang J
DOI：
10.1097/phh.0000000000001263
发表时间：
2021-01-01
影响因子：
3.3
作者：
Chen, Jarvis T.;Krieger, Nancy
通讯作者：
Krieger, Nancy
影响因子：
254.7
作者：
Fontham, Elizabeth T. H.;Wolf, Andrew M. D.;Smith, Robert A.
通讯作者：
Smith, Robert A.
影响因子：
15.8
作者：
Bassett MT;Chen JT;Krieger N
通讯作者：
Krieger N